硬化剂“双针法”介入注射治疗儿童体表静脉畸形的临床治疗研究

摘要

目的：分析和探讨采取硬化剂“双针法”介入注射治疗儿童体表静脉畸形的临床疗效。方法：回顾性分析41例静脉畸形患者采取“双针法”介入注射硬化剂治疗的临床资料。治疗前超声评估畸形静脉腔的体积，疗程结束后第6个月观察临床疗效及超声评估畸形静脉腔的体积缩小情况，同时观察术后近期及远期并发症，如肺栓塞、皮肤溃疡、局部肿胀、发热等。结果：所有患者在疗程结束后6个月时随访发现，治疗后畸形静脉腔的体积均较治疗前明显缩小，治疗均未出现严重不良并发症。结论：采取“双针法”硬化剂注射治疗儿童体表静脉畸形安全可靠，疗效确切，不良反应小，值得推广。%Objective:To analyze and discuss the clinical treatment of percutaneous interventional injecting sclerosing agent by double needle to treat childhood superficial venous malformations.Methods:Clinical data of 41 venous malformation cases were collect-ed.The volume of venous malformation was detected by ultrasound before treatment,and clinical efficacy and deformed venous contracti-ble volume was appraised 6 months after therapy session.Postoperative complications such as pulmonary embolism,skin ulcer,local swelling and fever were observed.Results:All patients received a complete therapy session,and were followed up after 6 months.The volume of venous malformation were significantly decreased after treatment (P <0.01 ).No adverse effects and severe complications were observed.Conclusion:The way of percutaneous interventional injecting sclerosing agent by double needle to treat childhood super-ficial venous malformations was worth spreading with reliable efficacy,safety and less incident of adverse effects.